Locations:
Search IconSearch

Research

nomogram
May 24, 2023/Cancer/Research

The Role of Nomograms in Treatment Evaluation for Cancer Patients (Podcast)

Optimized models can personalize predictions for patients with prostate, breast and other cancers

Lung cancer cells
March 28, 2023/Cancer/Research

Move to Next-Generation Sequencing of Non-Squamous Non-Small Cell Lung Cancer a Life Saver with Minimal Additional Cost

Lack of appropriate testing remains a barrier for patients eligible for targeted treatment

Re-irradiation therapy
March 9, 2023/Cancer/Research

Understanding the Role of Re-irradiation

Fine-tuning radiation for recurrent cancers

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Mobile mammography
February 17, 2023/Cancer/Research

Researchers Aim to Improve Cancer Outcomes Among People Experiencing Homelessness

Early interventions, improved screening access and tailored support services can help patients navigate cancer care

Novel Therapeutics Clinic
February 10, 2023/Cancer/Research

Novel Therapeutics Clinic Offers Access to Early-Phase Trials for Solid Tumors

Dedicated investigators and clinicians bring expertise in drug development and flexible study design

endometrial cancer
February 8, 2023/Cancer/Research

Not All Stage 1 and 2 Endometrial Cancers are Alike

Retrospective study aims to better stratify risk of disease recurrence

hospice care
January 31, 2023/Cancer/Research

Early Intervention Can Help Patients Benefit from Hospice Care at Home

Timely referral to hospice care reduces emergency room admissions

lymphoma
January 27, 2023/Cancer/Research

Pembrolizumab Following Autologous Stem Cell Transplantation Shows Promise in T-Cell Non-Hodgkin’s Lymphoma

62% of patients were progression-free at 18 months post-transplantation

Transfusion
January 24, 2023/Cancer/Research

Graft Failure Rates Negligible Between Patients with Haplo-Identical Donors and those with Matched Unrelated Donors Receiving Cyclophosphamide

Study assesses the impact of donor source and post-transplant prophylaxis for patients receiving a hematopoietic cell transplant

BackPage 7 of 27Next

Advertisement

Ad